Cornelia Ulrich, PhD, MS

Chief Scientific Officer and Executive Director of the Comprehensive Cancer Center, Huntsman Cancer Institute

Jon M. and Karen Huntsman Presidential Professor in Cancer Research

University of Utah, Salt Lake City, Utah

Dr. Cornelia Ulrich is the Executive Director of the Comprehensive Cancer Center at Huntsman Cancer Institute (HCI). She is also a Jon M. and Karen Huntsman Presidential Professor in Cancer Research in the Department of Population Health Sciences at the University of Utah. As Chief Scientific Officer and Cancer Center Executive Director, Dr. Ulrich oversees HCI’s academic consortium of more than 230 cancer research teams. She is a cancer epidemiologist whose research focuses on lifestyle and biologic factors in cancer prevention and cancer prognosis. Dr. Ulrich leads an interdisciplinary team of scientists on research related to the prevention, epidemiology, prognosis, and survivorship of cancer. She is also Principal Investigator of the HCI Total Cancer Care Protocol in the ORIEN network of cancer centers.

Ulrich’s lab has performed landmark research on colorectal cancer prevention and survivorship, including studies on biomarkers, aspirin and connections between obesity and physical activity in cancer prevention and survivorship. She has conducted several clinical trials, is the author of over 420 publications, and has served as principal investigator on more than 23 competitively funded research studies and clinical trials. She is a former Fulbright scholar, an elected member of the Board of the American Association of Cancer Institutes (AACI) and the European Academy of Cancer Sciences, a member of the Executive Leadership in Academic Medicine (ELAM) program, and serves on numerous editorial boards and advisory boards for agencies such as the National Institutes of Health (NIH), AACI, National Academies of Sciences and Medicine (NASEM), International Agency for Research on Cancer (IARC), and the American Association for Cancer Research (AACR).

Ulrich's research interests include: cancer epidemiology and cancer survivorship (esp. colorectal cancer), exercise intervention trials among cancer patients, exercise or energy balance impact biomarkers of cancer risk and outcomes, health behaviors and state-of-the-art biomarkers for cancer etiology, treatment, and and survivorship.